SCHEMBL8971016

SCHEMBL8971016

O=C1c2ccccc2C(=O)N1C(CCc1ccccc1)C1CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CASP3 P42574 2/20 0.40
ALDH1A1 P00352 3/20 0.40
POLB P06746 3/20 0.40
NR1H3 Q13133 2/20 0.40
NR1H2 P55055 1/20 0.40
GAA P10253 1/20 0.40
GBA1 P04062 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
CYP1A2 P05177 1/20 0.36
HRH1 P35367 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TP53 P04637 1/20 0.36
GLA P06280 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8971090 0.82 ALDH1A1 (0.46) SLC6A4SLC6A2SLC6A3ALDH1A1POLB
SCHEMBL9427633 0.81 ALDH1A1 (0.45) TDP1SLC6A4SLC6A2SLC6A3ALDH1A1
SCHEMBL493666 0.74 MC4R (0.48) SLC6A4SLC6A2SLC6A3GBA1HRH1
SCHEMBL9427132 0.73 ALDH1A1 (0.40) TDP1CASP3ALDH1A1POLBNR1H3
SCHEMBL1569173 0.73 TDP1 (0.37) TDP1SLC6A4SLC6A2SLC6A3CASP3
SCHEMBL4759577 0.73 TNF (0.43) TDP1ALDH1A1POLBGAAL3MBTL1
SCHEMBL8500434 0.71 CYP1A2 (0.39) SLC6A4SLC6A2SLC6A3CYP1A2
SCHEMBL7875085 0.71 GBA1 (0.47) SLC6A4SLC6A2SLC6A3GBA1CYP1A2
SCHEMBL8969997 0.71 GBA1 (0.47) SLC6A4SLC6A2SLC6A3GBA1HRH1
SCHEMBL9978780 0.71 GBA1 (0.47) SLC6A4SLC6A2SLC6A3GBA1HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5480892-A SIGMA RECEPTOR ANTAGONISTS; TREATMENT OF PHYSIOLOGICAL OR DRUG INDUCED PSYCHOSIS AND DYSKINESIA THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-01-02 US disclosed
US-5356906-A (N-phthalimidoalkyl) piperidines useful as treatments for psychosis THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-10-18 US disclosed
WO-1993022310-A1 (N-PHTHALIMIDOALKYL)PIPERIDINES FOR THE TREATMENT OF PSYCHOSES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-11-11 WO disclosed
WO-1991006297-A1 (N-PHTHALIMIDOALKYL) PIPERIDINES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1991-05-16 WO disclosed